In today’s recent session, 0.66 million shares of the Prothena Corporation plc (NASDAQ:PRTA) have been traded, and its beta is 0.12. Most recently the company’s share price was $8.56, and it changed around $0.48 or 5.88% from the last close, which brings the market valuation of the company to $460.49M. PRTA at last check was trading at a discount to its 52-week high of $25.42, offering almost -196.96% off that amount. The share price’s 52-week low was $8.00, which indicates that the recent value has risen by an impressive 6.54% since then.
Prothena Corporation plc stock received a consensus recommendation rating of Buy, based on a mean score of 1.40. If we narrow it down even further, the data shows that 0 out of 10 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 2 recommended PRTA as a Hold, whereas 5 deemed it a Buy, and 0 rated it as Underweight. Prothena Corporation plc is expected to report earnings per share of -1.03 for the current quarter.
Prothena Corporation plc (NASDAQ:PRTA) trade information
Instantly PRTA has been showing a green trend so far today with a performance of 5.88% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 9.57 on recent trading dayincreased the stock’s daily price by 10.55%. The company’s shares are currently down -38.23% year-to-date, but still down -11.71% over the last five days. On the other hand, Prothena Corporation plc (NASDAQ:PRTA) is -21.22% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $56, which translates to bulls needing to increase their stock price by 84.71% from its current value. Analyst projections state that PRTA is forecast to be at a low of $24 and a high of $98.
Prothena Corporation plc (PRTA) estimates and forecasts
The year-over-year growth rate is expected to be -62.56%, down from the previous year.
Consensus estimates provided by 7 financial analysts predict the company will bring in an average of 8.18M in revenue for the current quarter. 7 analysts expect Prothena Corporation plc to make 15.34M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 50k and 132.01M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 16,257.14%. Forecasts for the next quarter put sales growth at -88.38%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -3.15%. Prothena Corporation plc earnings are expected to increase by -54.33% in 2025, but the outlook is negative -15.39% per year for the next five years.
PRTA Dividends
Prothena Corporation plc’s next quarterly earnings report is expected to be released on 2025-Feb-19.
FMR LLC, with 15.0012% or 8.07 million shares worth $166.48 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund and Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund were the top two Mutual Funds as of Jan 31, 2025 . The former held 4.22 shares worth $35.82 million, making up 7.84% of all outstanding shares. On the other hand, Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund held roughly 2.32 shares worth around $19.68 million, which represents about 4.31% of the total shares outstanding.
